Brief: Proqr Announces Encouraging Ax-0810 Phase 1

ProQR Therapeutics NV

08/01/2026 13:39

Jan 8 (Reuters) - ProQR Therapeutics NV PRQR.O:

PROQR ANNOUNCES ENCOURAGING AX-0810 PHASE 1 SAFETY AND PK DATA, DEVELOPMENT CANDIDATE SELECTIONS, AND 2026 OUTLOOK

PROQR THERAPEUTICS NV: INITIAL AX-0810 DATA SHOW NO SAFETY SIGNALS AFTER 4 WEEKS OF DOSING AND PHARMACOKINETICS CONSISTENT WITH NON-CLINICAL DATA

PROQR THERAPEUTICS NV: PHASE 1 AX-0810 DATA EXPECTED IN H1 2026

Source text: ID:nGNX2gkps5

Further company coverage: PRQR.O

 ((Reuters.Briefs@thomsonreuters.com;))